GLP-1 receptor agonists (semaglutide, tirzepatide), titration, side-effect management, and clinical context for compounded weight-loss therapies.
One of the first questions people ask before starting GLP 1 treatment: do I have to stay on this forever? Here is the honest answer, what the research shows about stopping, and what long term care actually looks like.
Your scale says you lost 30 pounds. It cannot tell you how much was muscle. Here is why a DEXA scan changes the whole picture on GLP 1, and what to do with what it shows.
Wondering what actually happens at a first appointment for weight loss medication? Here is the full walk through, from health history and labs to your personalized plan, so you know exactly what to expect.
GLP-1 medications are titrated slowly for a reason. Here is the pharmacological rationale, the standard escalation schedules for semaglutide and tirzepatide, and what to expect at each step.
Compounded semaglutide and tirzepatide differ from branded GLP-1s in regulation, sourcing, and FDA status. Here's what patients need to know.
GLP-1 receptor agonists like semaglutide and tirzepatide can cause nausea, constipation, and other GI side effects. Here's how to manage them.
